Table of Contents
In this article, we’ll cover some of the applications of this natural compound, including Glaucoma treatment. But before we can talk about the potential uses of this compound, it must undergo extensive safety and efficacy studies.
Cannabigerol is a hemp-derived anti-anxiety compound. It is used to treat OCD, PTSD, and depression symptoms. It functions by binding to the five-HT1A receptor found in the brain. However, there are several concerns about the safety of cannabigerol. This is why additional research is necessary to ensure that it is safe for human use. The researchers polled 121 cannabis users and discovered that it was most commonly used to treat anxiety (51.2%), chronic pain (40.9%), depression (33.1%), and insomnia/disturbed sleep (30.7%). Most said their symptoms had improved “significantly,” with 80% saying CBG-rich cannabis worked better than conventional medicine for depression, 78.3% for anxiety, 73.9% for chronic pain, and 73% for insomnia. However, some respondents also reported mild side effects similar to those associated with regular cannabis, such as dry mouth, sleepiness, dry eyes, and increased appetite.
There are many different cannabinoids found in cannabis, and cannabigerol oil is just one of them. Cannabigerol is similar to CBD but does not produce a euphoric high. It also does not impair your thinking. It is slightly better for neuroprotection and the anti-bacterial properties of MRSA. But it’s still a relatively small part of a complex mixture of chemicals.
Cannabidiol (CBD) is a natural product produced by Cannabis sativa, a plant that contains less than 0.3% THC. The difference between marijuana and hemp is its THC or psychoactive cannabinoid level. CBD increases the effects of THC by potentiating its effect on the human body. In addition, this cannabinoid reduces stress by preventing the occurrence of chronic anxiety.
Cannabigerol is a precursor to other cannabinoids, including cannabidiol and tetrahydrocannabinol. While these two compounds have similar effects, the chemical structure of cannabigerol makes them distinct. Cannabidiol (CBD) can reduce pain and inflammation, while cannabigerol doesn’t induce a euphoric high. It’s also not psychoactive and has no adverse side effects, such as impaired thinking and intoxication. However, CBG is slightly more effective against MRSA bacteria than CBD.
The use of medical marijuana for glaucoma treatment has been discussed for decades. It is believed to reduce IOP and provide neuroprotection to retinal ganglion cells. However, the drug’s efficacy depends on the cannabinoid used and its mode of administration. Several factors may affect the effectiveness of cannabinoid treatments for glaucoma.
Inflammatory bowel disease (IBD) is a chronic condition that causes bowel inflammation and affects millions of people worldwide. Researchers found that CBG decreased inflammation, reduced nitric oxide production, and prevented the formation of reactive oxygen species in the intestine. In addition, CBG has been used to combat Huntington’s disease in mice.
One of the most common forms of glaucoma is open-angle glaucoma. It causes patchy blind spots. The optic nerve is the connection between the eye and the brain. Once damaged, it is challenging to recover vision. The most common type of glaucoma is the slow-developing variety. The drainage channels in the eye gradually become clogged over time.